Furthermore, ChIP assays revealed that downregulation of NKX2-8 significantly reduced, whereas upregulation of NKX2-8 enriched, the HDAC1 level on the PTHrP promoter in breast cancer cells (Figure 5B). Here, NKX2-8 is linked to breast carcinoma.